Vaccine Stocks Jump on Report of New Coronavirus Study in China

Feb. 21, 2025, 6:12 PM UTC

Shares of Covid-19 vaccine makers spiked Friday afternoon in New York as traders shared earlier reports about a new coronavirus study in China.

  • The South China Morning Post reported late Thursday New York time that a research team in China had found a new bat coronavirus that they say could risk animal-to-human transmission
    • Report says the new virus has the same human receptor as the virus that causes Covid-19
  • Moderna rose as much as 6.4%, BioNTech ADRs were up as much as 5.1%, Pfizer gained as much as 1.7%, Novavax climbed as much as 7.3%

To contact the reporter on ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.